Close Menu

SAN FRANCISCO (GenomeWeb) - NanoString is on target to launch GeoMx, its Digital Spatial Profiler that analyzes proteins and RNA within their spatial context, at the American Association of Cancer Research meeting in March, CEO Brad Gray said during his presentation at the annual JP Morgan Healthcare Conference held here.

The company installed its first beta system at a customer site near the end of 2018 and plans to complete installation for its eight beta customers during the first quarter 2019.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

In PLOS this week: transcriptomic and genomic analysis of prostate cancer by ancestry, genes linked to liver function in Korean cohort, and more.

British Columbia is incorporating genomics into its tracking of the ongoing COVID-19 outbreak, Business in Vancouver reports.

An analysis by the Personalized Medicine Coalition finds that about a quarter of new drugs approved in 2019 by the US Food and Drug Administration were personalized medicines.

The governor of New York has proposed a five-year plan to study the genomes of people with or who are at high risk of developing Alzheimer's disease.